361456-46-4

Basic information

• Product Name: 4-(Bromomethyl)-3-fluorobenzoicacid
• CAS NO: 361456-46-4
• Molecular Formula: C₈H₆BrFO₂
• Molecular Weight: 233.0344432
• Mol File: 361456-46-4.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(Bromomethyl)-3-fluorobenzoicacid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(Bromomethyl)-3-fluorobenzoicacid(361456-46-4)
• EPA Substance Registry System: 4-(Bromomethyl)-3-fluorobenzoicacid(361456-46-4)

Safety Data

• Hazardous Substances Data: 361456-46-4(Hazardous Substances Data)

Upstream product

• 350-28-7 3-fluoro-4-methyl-benzoic acid 
• 51436-99-8 2-fluoro-4-bromotoluene 
• 60956-26-5 4-bromo-2-nitrotoluene 
• 39478-78-9 5-bromo-2-methylaniline 
• 119-32-4 4-Methyl-3-nitroanilin 

Downstream Products

• 477199-79-4 3-fluoro-4-methoxymethylbenzoic acid 

Relevant articles and documents

ENZYME INHIBITORS

This invention relates to enzyme inhibitors that are inhibitors of plasma kallikrein and to pharmaceutical compositions containing and the uses of, such inhibitors.Specifically, the invention relates to compounds of formula (I): Formula (I) and tautomers,stereoisomers, pharmaceutically acceptable salts and solvates thereof; wherein R1 to R15, and Q are as defined herein.

THIAZOLE DERIVATIVE AND USE THEREOF AS VAP-1 INHIBITOR

The present invention provides a novel thiazole derivative useful as a VAP-1 inhibitor, a pharmaceutical agent for the prophylaxis or treatment of VAP-1 associated diseases and the like. A compound represented by the formula (I): wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof.

PHARMACEUTICAL PREPARATIONS COMPRISING INSULIN, ZINC IONS AND A ZINC-BINDING LIGAND

Novel preparations comprising branched ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer. The preparations have a prolonged action designed for flexible injection regimes.